As reported at the European Society of Cardiology in Amsterdam, among patients with 0-2 stroke risk factors, those with atrial fibrillation had a three-fold risk of stroke over those who didn’t have afib. But that difference declined as the number of risk factors increased. The risk of stroke was high in those with 3 or …
Read More
The European Heart Rhythm Association (EHRA), a part of the European Society of Cardiology (ESC), has launched the Afibmatters.org web site for atrial fibrillation patients. StopAfib.org was honored to collaborate on this site to help meet patient needs. Learn more at: Atrial fibrillation patient website afibmatters.org launched by European Society of Cardiology
Read More
StopAfib.org had the great privilege of participating in the launch of the Global Atrial Fibrillation Patient Charter and the Sign Against Stroke in Atrial Fibrillation campaign at the World Congress of Cardiology in Dubai. To learn more about this independent patient charter, which StopAfib.org participated in developing, and to sign the charter, see: Global Atrial …
Read More
Mellanie True Hills, founder of StopAfib.org, spoke at the Fifth Annual Western Atrial Fibrillation Symposium medical conference. Her remarks are summarized in her patient perspective column in the April 2012 issue of EP Lab Digest. See: How Social Media Helps Educate Afib Patients: An Atrial Fibrillation Patient Perspective Published in EP Lab Digest, April, 2012
Read More
As the founder of StopAfib.org, I have heard from thousands of atrial fibrillation patients who have shared their afib experiences with me. For so many of us, the diagnosis and treatment of afib is confusing and scary. To improve communication between patients and their health-care providers, and ultimately, provide better care, I recently shared with …
Read More
We have received word of a study at Vanderbilt University to determine if fish oil supplements decrease afib. Below is the info they sent in case you are interested in participating and are in the Nashville, Tennessee area… Recruiting Patients with Atrial Fibrillation We are recruiting patients with atrial fibrillation to participate in an NIH-sponsored …
Read More
watchLAB is conducting a market research study by phone with Atrial Fibrillation patients throughout the US who have had both chemical (IV) and electrical cardioversions, preferably in the past 2 years. See below for the definitions they have supplied to help you determine if you are qualified to participate. If you qualify, you will be …
Read More
Mellanie True Hills, founder of StopAfib.org, recently spoke at the Fourth Annual Western Atrial Fibrillation Symposium. Many of her remarks to this medical conference are summarized in an article just published in EP Lab Digest. You may wish to share it with family and friends who need to understand what it's like to live with …
Read More
watchLAB is hosting a market research study in Los Angeles, Pittsburgh and Seattle with Atrial Fibrillation patients who have experienced both chemical (IV) and electrical cardioversion, preferably in the past 2 years. If you qualify, you will be invited to participate in a one hour interview or a small 1.5-hour group discussion to share your …
Read More
New research from Denmark shows that CHADS2 underestimates stroke risk. In the study, atrial fibrillation patients who were at intermediate risk with the CHADS2 scoring system had more than twice the stroke rate of those defined by the enhanced CHA2DS2-VASc tool as being at intermediate risk. While CHADS2 deemed 32.3% of patients to have intermediate …
Read More